Our Medicines
The below table provides an overview of all Janssen medicines available in New Zealand
Please click on the product entry to see a short overview of the medicine as well as the Consumer Medicine Information (CMI) sheet and a Product Data Sheet designed for Healthcare Professionals. Information on this site is not medical advice.
FILTER RESULTS BY:
Janssen Medicines in New Zealand
IMBRUVICA®
(ibrutinib)Chronic Lymphocytic Leukaemia, Mantle cell leukemia, Small lymphocytic lymphoma
REMICADE®
(infliximab)Ankylosing spondylitis, Crohn’s Disease, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis
RIBOMUSTIN®
(bendamustine [as hydrochloride])Chronic Lymphocytic Leukaemia, Mantle Cell Lymphoma, Non Hodgkin Lymphoma
SIMPONI®
(golimumab [rmc] ) (Not Available)Ankylosing spondylitis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis
You are about to leave a Janssen New Zealand controlled website. The information you are being referred to may not comply with the New Zealand regulatory requirements and you should refer to the relevant Consumer Medicines Information (CMI) for any products to fully understand the terms of that product’s registration in New Zealand. Janssen New Zealand is not responsible for the content of the website you are entering. Proceed?